Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe

dc.contributor.authorChloe J Bright
dc.contributor.authorMike M Hawkins
dc.contributor.authorDavid L Winter
dc.contributor.authorDaniela Alessi
dc.contributor.authorRodrigue S Allodji
dc.contributor.authorFrancesca Bagnasco
dc.contributor.authorEdit Bárdi
dc.contributor.authorAndrea Bautz
dc.contributor.authorJulianne Byrne
dc.contributor.authorElizabeth A M Feijen
dc.contributor.authorMiranda M Fidler
dc.contributor.authorStanislaw Garwicz
dc.contributor.authorDesiree Grabow
dc.contributor.authorThorgerdur Gudmundsdottir
dc.contributor.authorJoyeeta Guha
dc.contributor.authorNadia Haddy
dc.contributor.authorMomcilo Jankovic
dc.contributor.authorPeter Kaatsch
dc.contributor.authorMelanie Kaiser
dc.contributor.authorClaudia E Kuehni
dc.contributor.authorHelena Linge
dc.contributor.authorHilde Øfstaas
dc.contributor.authorCecile M Ronckers
dc.contributor.authorRoderick Skinner
dc.contributor.authorJop C Teepen
dc.contributor.authorMonica Terenziani
dc.contributor.authorGiao Vu-Bezin
dc.contributor.authorFinn Wesenberg
dc.contributor.authorThomas Wiebe
dc.contributor.authorCarlotta Sacerdote
dc.contributor.authorZsuzsanna Jakab
dc.contributor.authorRiccardo Haupt
dc.contributor.authorPäivi Lähteenmäki
dc.contributor.authorLorna Zadravec Zaletel
dc.contributor.authorRahel Kuonen
dc.contributor.authorJeanette F Winther
dc.contributor.authorFlorent de Vathaire
dc.contributor.authorLeontien C Kremer
dc.contributor.authorLars Hjorth
dc.contributor.authorRaoul C Reulen
dc.contributor.authorPanCareSurFup Consortium
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.converis.publication-id45521909
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/45521909
dc.date.accessioned2022-10-27T12:28:20Z
dc.date.available2022-10-27T12:28:20Z
dc.description.abstractChildhood cancer survivors are at risk of subsequent primary soft-tissue sarcomas (STS), but the risks of specific STS histological subtypes are unknown. We quantified the risk of STS histological subtypes after specific types of childhood cancer.\nWe pooled data from 13 European cohorts, yielding a cohort of 69 460 five-year survivors of childhood cancer. Standardized incidence ratios (SIRs) and absolute excess risks (AERs) were calculated.<div>Overall, 301 STS developed compared with 19 expected (SIR = 15.7, 95% confidence interval [CI] = 14.0 to 17.6). The highest standardized incidence ratios were for malignant peripheral nerve sheath tumors (MPNST; SIR = 40.6, 95% CI = 29.6 to 54.3), leiomyosarcomas (SIR = 29.9, 95% CI = 23.7 to 37.2), and fibromatous neoplasms (SIR = 12.3, 95% CI = 9.3 to 16.0). SIRs for MPNST were highest following central nervous system tumors (SIR = 80.5, 95% CI = 48.4 to 125.7), Hodgkin lymphoma (SIR = 81.3, 95% CI = 35.1 to 160.1), and Wilms tumor (SIR = 76.0, 95% CI = 27.9 to 165.4). Standardized incidence ratios for leiomyosarcoma were highest following retinoblastoma (SIR = 342.9, 95% CI = 245.0 to 466.9) and Wilms tumor (SIR = 74.2, 95% CI = 37.1 to 132.8). AERs for all STS subtypes were generally low at all years from diagnosis (AER < 1 per 10 000 person-years), except for leiomyosarcoma following retinoblastoma, for which the AER reached 52.7 (95% CI = 20.0 to 85.5) per 10 000 person-years among patients who had survived at least 45 years from diagnosis of retinoblastoma.\nFor the first time, we provide risk estimates of specific STS subtypes following childhood cancers and give evidence that risks of MPNSTs, leiomyosarcomas, and fibromatous neoplasms are particularly increased. While the multiplicative excess risks relative to the general population are substantial, the absolute excess risk of developing any STS subtype is low, except for leiomyosarcoma after retinoblastoma. These results are likely to be informative for both survivors and health care providers.</div>
dc.format.pagerange649
dc.format.pagerange660
dc.identifier.eissn1460-2105
dc.identifier.jour-issn0027-8874
dc.identifier.olddbid175731
dc.identifier.oldhandle10024/158825
dc.identifier.urihttps://www.utupub.fi/handle/11111/31546
dc.identifier.urnURN:NBN:fi-fe2021042823954
dc.language.isoen
dc.okm.affiliatedauthorLähteenmäki, Päivi
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherOxford University Press
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1093/jnci/djx235
dc.relation.ispartofjournalJNCI: Journal of the National Cancer Institute
dc.relation.issue6
dc.relation.volume110
dc.source.identifierhttps://www.utupub.fi/handle/10024/158825
dc.titleRisk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe
dc.year.issued2018

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
djx235.pdf
Size:
811.53 KB
Format:
Adobe Portable Document Format
Description:
Publisher's version